This entry is part of the Nutri Tailor Health Reference Library — cited research on supplements, nutrients and adjacent areas of health.
Glutamine has one genuinely strong trial behind the gut claims, and knowing its boundaries is the whole game. In people whose diarrhoea predominant IBS began after a gut infection, with intestinal permeability confirmed as raised, 15 g a day for 8 weeks produced response in 79.6 percent against 5.8 percent on placebo. Outside that specific picture the evidence thins fast, with no support for constipation type IBS, unmeasured gut complaints, or recovery in well fed athletes, because healthy bodies synthesise abundant glutamine already. The trial used 5 g three times daily, which is powder territory, as capsules at 400 mg reach 2.4 g a day at 6 capsules, useful for gentler support but not the trial protocol.
Enterocytes, the cells lining the small intestine, use glutamine as their primary fuel, and glutamine supports the tight junction proteins that control what passes between those cells. Immune cells including lymphocytes also consume glutamine heavily. Under normal conditions the body synthesises all it needs, and the supplemental case rests on situations where demand outruns synthesis or where the gut lining is under repair.
The landmark gut trial used 5 g three times daily, 15 g in total, for 8 weeks. Clinical nutrition settings use up to 0.3 to 0.5 g per kg under supervision. For general support without active symptoms, 2 to 5 g daily is common practice without strong trial backing at that level. At 400 mg per capsule, 6 capsules deliver 2.4 g, and reaching trial territory means powder.
L-glutamine is a single amino acid and identical across products, so the real decision is capsules against powder, decided by dose. Powder mixed in water is the only practical route to 10 to 15 g daily, while capsules suit lower maintenance amounts and travel. Take powder in cool liquid, since glutamine degrades in prolonged heat.
The trial split dosing across three points in the day, and splitting makes sense because the gut can only use so much per absorptive window. Empty stomach timing is not required. Consistency across the full 8 week window mattered in the research, and shorter casual use has no equivalent evidence.
Glutamine is well tolerated, with doses up to 30 g daily used in trials and higher under clinical supervision without significant adverse effects in most settings. Mild digestive discomfort at the start of higher doses is the common complaint. People with liver or kidney disease should involve their clinician first, because amino acid loads are handled by exactly those organs.
The evidence supported group is adults whose diarrhoea predominant IBS pattern started after a confirmed or strongly suspected gut infection. Anyone with ongoing significant bowel symptoms should have a GP conversation before self supplementing, because symptom patterns that look like IBS need proper assessment first, and a supplement should never delay that. People with liver or kidney conditions need clinical input. Pregnancy data at supplemental doses is limited, so food protein remains the route there.
No significant interactions with prescribed drugs at nutritional doses. Glutamine is compatible with probiotics and standard gut support approaches. In epilepsy care and some rare metabolic conditions clinicians manage amino acid intake specifically, and those situations belong with the specialist.
No UK intake reference exists because glutamine is synthesised endogenously and classed as conditionally essential. The evidence anchors are the 2019 randomised double blind trial in Gut showing a 14 fold response difference in post infection diarrhoea predominant IBS with confirmed permeability changes at 15 g daily, and the clinical nutrition literature establishing tolerance of high doses. A 2021 trial in mixed type IBS found more modest effects, mapping the boundary of who benefits.
Match the protocol to the picture. If your bowel pattern turned loose after a gut infection and stayed that way, the evidence backed pattern is 5 g of glutamine powder three times daily for 8 weeks, judged on stool frequency and symptom severity, ideally with a GP aware. For gentler ongoing gut support, 2 to 3 g daily is reasonable practice at capsule friendly amounts, and Nutri Tailor stocks pure L-glutamine at 400 mg per capsule, dosed at 6 capsules for 2.4 g daily, at nutritailor.co.uk/products/glutamine. If 8 weeks at a proper dose changes nothing, stop and reassess with a professional rather than continuing on hope.
Glutamine is not a general gut answer, and the standout trial result belongs to one specific group with measured permeability changes after infection. Leaky gut as a catch all self diagnosis outruns the science, and permeability is measurable rather than guessable. Athletes eating adequate protein already consume and synthesise substantial glutamine, and supplementation has not shown meaningful performance or immunity effects in that group. And capsules at label doses do not deliver the amounts the strong research used.